NCT05091866View on ClinicalTrials.gov

Natural Progesterone for the Treatment of Recurrent Glioblastoma

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 11, 2022

Primary Completion Date

August 25, 2025

Study Completion Date

August 25, 2026

Conditions
GliosarcomaRecurrent Glioblastoma
Interventions
OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

BIOLOGICAL

Therapeutic Progesterone

Given SC

Trial Locations (1)

30322

RECRUITING

Emory University Hospital/Winship Cancer Institute, Atlanta

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Emory University

OTHER